Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
نویسندگان
چکیده
منابع مشابه
Oncolytic Viruses as Therapeutic Agents for Prostate Cancer
Viruses are commonly thought of as opportunistic organisms that hijack cellular machinery with the ultimate goal of replicating and causing destruction in the host. However, viruses are increasingly being explored as therapeutic agents for a variety of disorders and diseases, including cancers, due to their natural ability to spread to various cell types. Oncolytic viruses are replication-compe...
متن کاملSensitivity of Breast Tumors to Oncolytic Viruses
Department of Defense Breast Cancer Research Program Meeting, 2005. Sensitivity of Breast Tumors to Oncolytic Viruses. Seminar: Breast Cancer Center of Excellence, Wake Forest University Health Sciences, 2006. Treatment of Breast Cancer with Oncolytic VSV.
متن کاملOncolytic Viruses as Anticancer Vaccines
Oncolytic virotherapy has shown impressive results in preclinical studies and first promising therapeutic outcomes in clinical trials as well. Since viruses are known for a long time as excellent vaccination agents, oncolytic viruses are now designed as novel anticancer agents combining the aspect of lysis-dependent cytoreductive activity with concomitant induction of antitumoral immune respons...
متن کاملOncolytic viruses for the therapy of brain tumors and other solid malignancies: a review.
In spite of significant advances in the understanding of molecular processes in tumor biology that have led to the development of oncologic therapeutic strategies, the prognosis for several types of tumors (such as brain, pancreas, or hepatic malignancies) remains dismal. Without question, a strong need exists for continued investigations in new agents and new therapeutic regimens. The realizat...
متن کاملMolecular mechanisms and therapeutic targets in pediatric brain tumors.
Brain tumors are among the leading causes of cancer-related deaths in children. Although surgery, aggressive radiation, and chemotherapy have improved outcomes, many patients still die of their disease. Moreover, those who survive often suffer devastating long-term side effects from the therapies. A greater understanding of the molecular underpinnings of these diseases will drive the developmen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancers
سال: 2018
ISSN: 2072-6694
DOI: 10.3390/cancers10070226